DIAGNOS Statistics
Total Valuation
DIAGNOS has a market cap or net worth of 27.47 million. The enterprise value is 28.68 million.
| Market Cap | 27.47M |
| Enterprise Value | 28.68M |
Important Dates
The next estimated earnings date is Friday, February 20, 2026.
| Earnings Date | Feb 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 120.41M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +28.74% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 4.42% |
| Owned by Institutions (%) | n/a |
| Float | 115.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 484.33 |
| PB Ratio | -24.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.39 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.80 |
Financial Position
The company has a current ratio of 0.39
| Current Ratio | 0.39 |
| Quick Ratio | 0.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.59 |
| Interest Coverage | -8.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -137.41% |
| Return on Invested Capital (ROIC) | -173.20% |
| Return on Capital Employed (ROCE) | 367.49% |
| Weighted Average Cost of Capital (WACC) | 4.05% |
| Revenue Per Employee | 2,578 |
| Profits Per Employee | -155,337 |
| Employee Count | 22 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.68% in the last 52 weeks. The beta is -0.19, so DIAGNOS's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | +1.68% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.20 |
| Relative Strength Index (RSI) | 46.04 |
| Average Volume (20 Days) | 82,617 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DIAGNOS had revenue of 56,713 and -3.42 million in losses. Loss per share was -0.03.
| Revenue | 56,713 |
| Gross Profit | -931,712 |
| Operating Income | -3.17M |
| Pretax Income | -3.42M |
| Net Income | -3.42M |
| EBITDA | -3.16M |
| EBIT | -3.17M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 529,294 in cash and 1.71 million in debt, with a net cash position of -1.18 million.
| Cash & Cash Equivalents | 529,294 |
| Total Debt | 1.71M |
| Net Cash | -1.18M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.10M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.04M |
Cash Flow
In the last 12 months, operating cash flow was -2.92 million and capital expenditures -10,266, giving a free cash flow of -2.93 million.
| Operating Cash Flow | -2.92M |
| Capital Expenditures | -10,266 |
| Free Cash Flow | -2.93M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -5,591.36% |
| Pretax Margin | -6,025.81% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DIAGNOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.74% |
| Shareholder Yield | -28.74% |
| Earnings Yield | -12.44% |
| FCF Yield | -10.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
DIAGNOS has an Altman Z-Score of -75.97 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -75.97 |
| Piotroski F-Score | 2 |